Correlates of Adverse Outcomes in Abdominally Obese Individuals: Findings from the Five-Year Followup of the Population-Based Study of Health in Pomerania
Author(s) -
Nele Friedrich,
Harald J. Schneider,
Ulrich John,
Marcus Dörr,
Sebastian E. Baumeister,
Georg Homuth,
Uwe Völker,
Henri Wallaschofski
Publication year - 2013
Publication title -
journal of obesity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.756
H-Index - 53
eISSN - 2090-0716
pISSN - 2090-0708
DOI - 10.1155/2013/762012
Subject(s) - medicine , abdominal obesity , waist , obesity , incidence (geometry) , type 2 diabetes , population , risk factor , diabetes mellitus , disease , kidney disease , endocrinology , environmental health , physics , optics
Background . Abdominal obesity is a major risk factor of cardiovascular disease (CVD), type 2 diabetes (T2DM), and premature death. However, it has not been resolved which factors predispose for the development of these adverse obesity-related outcomes in otherwise healthy individuals with abdominal obesity. Methods . We studied 1,506 abdominal obese individuals (waist-to-height ratio (WHtR) ≥ 0.5) free of CVD or T2DM from the population-based Study of Health in Pomerania and assessed the incidence of CVD or T2DM after a five-year followup. Logistic regression models were adjusted for major cardiovascular risk factors and liver, kidney diseases, and sociodemographic status. Results . During follow-up time, we observed 114 and 136 new T2DM and CVD cases, respectively. Regression models identified age, waist circumference, serum glucose, and liver disease as predictors of T2DM. Regarding CVD, only age, unemployment, and a divorced or widowed marital status were significantly associated with incident CVD. In this subgroup of obese individuals blood pressure, serum glucose, or lipids did not influence incidence of T2DM or CVD. Conclusion . We identified various factors associated with an increased risk of incident T2DM and CVD among abdominally obese individuals. These findings may improve the detection of high-risk individuals and help to advance prevention strategies in abdominal obesity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom